Summary
Ecolab Inc. reported solid financial results for the second quarter and first six months of 2017, demonstrating growth in net sales and net income attributable to Ecolab compared to the prior year. Net sales increased by 4% to $3.5 billion in the second quarter and 3% to $6.6 billion for the first six months. Net income attributable to Ecolab rose by 15% to $296.6 million in the quarter and 12% to $550.1 million for the year-to-date period. The company's performance was bolstered by strength in its Global Industrial and Global Institutional segments, with notable contributions from its Water, Food & Beverage, Paper, and Healthcare businesses. Despite a decrease in adjusted gross margin due to higher delivered product costs and an unfavorable currency hedge impact, the company's SG&A expenses as a percentage of sales improved. Ecolab also announced new restructuring and cost-saving actions aimed at streamlining operations, which are expected to yield benefits in the latter half of the year. The company's acquisition of Anios in early 2017 contributed significantly to asset growth and is expected to expand its offerings in the hygiene and disinfection market. Overall, Ecolab demonstrated resilience and growth, managing costs effectively while investing in strategic initiatives.
Financial Highlights
54 data points| Revenue | $3.46B |
| Cost of Revenue | $2.04B |
| Gross Profit | $1.43B |
| SG&A Expenses | $967.00M |
| Operating Income | $419.60M |
| Interest Expense | $63.70M |
| Net Income | $294.80M |
| EPS (Basic) | $1.02 |
| EPS (Diluted) | $1.00 |
| Shares Outstanding (Basic) | 289.80M |
| Shares Outstanding (Diluted) | 294.10M |
Key Highlights
- 1Net sales increased by 4% to $3.5 billion for the second quarter ended June 30, 2017, compared to $3.3 billion in the prior year.
- 2Net income attributable to Ecolab rose 15% to $296.6 million in the second quarter, or $1.01 per diluted share, up from $0.87 per diluted share in the prior year.
- 3The Anios acquisition, completed in February 2017 for $798.3 million, is integrated into the Global Institutional segment and is expected to expand Ecolab's healthcare market presence.
- 4Special charges decreased significantly to $61.2 million in the second quarter of 2017, down from $88.1 million in the same period of 2016, primarily due to the absence of energy-related charges.
- 5Selling, General, and Administrative (SG&A) expenses as a percentage of sales improved to 32.2% in the second quarter of 2017 from 33.0% in the prior year, indicating improved cost management.
- 6The company announced restructuring and cost-saving actions in Q2 2017, including a global workforce reduction of approximately 530 positions, expected to result in charges of $40-45 million.
- 7Ecolab's debt-to-EBITDA ratio improved to 2.6x at June 30, 2017, from 2.8x at the end of 2016, indicating a stronger leverage position.